Value Investing Alert: Abbott or Syncom Formulations — Which Is Worth Buying Now? | Sagar Yadav скачать в хорошем качестве

Value Investing Alert: Abbott or Syncom Formulations — Which Is Worth Buying Now? | Sagar Yadav

When you invest in a fundamentally strong company at a good valuation, two things happen 1️⃣ The chances of the stock falling further are low, and 2️⃣ Even if short-term returns are limited, long-term gains are usually strong. That’s why finding value at the right price matters! In today’s video, we’ll discuss two pharma stocks — one small-cap and one large-cap both of which look fundamentally strong and are currently available at fair valuations. Let’s find out whether these stocks are a real value buying opportunity or not! 💊📈 #ValueInvesting #PharmaStocks #StockAnalysis #SyncomFormulations #AbbottIndia #InvestingIndia #StockMarket Disclaimer: This is for education and awareness purpose only, please do your own research before investing your hard earned money. Please Note: The information shared in this video is based on my personal research and understanding, and is true to the best of my knowledge. However, if any mistake or oversight has occurred, it is completely unintentional. If you notice any such issue, please feel free to reach out at [email protected] (use the subject line: FEEDBACK) so that I can take appropriate action and resolve it amicably.